Two-Year Results for New Alopecia Areata Treatment LEQSELVI® Showcase Effectiveness and Safety #United_States #Princeton,_NJ #Alopecia_Areata #LEQSELVI #deuruxolitinib

In a phase 2 dose-optimization study led by Brett King, MD, 8 mg of #deuruxolitinib twice daily was more effective than 16 mg once daily for patients with severe #AlopeciaAreata. #Dermatology

www.docwirenews.com/post/all-day...